Anastasia A. Zenchenko, Irina V. Varizhuk, Mikhail S. Drenichev, Vladimir E. Oslovsky
{"title":"Synthesis of O-Nicotinoyl-Substituted Depot Forms of Biologically Active N6-Benzyladenosine Analogs","authors":"Anastasia A. Zenchenko, Irina V. Varizhuk, Mikhail S. Drenichev, Vladimir E. Oslovsky","doi":"10.1002/cpz1.70121","DOIUrl":null,"url":null,"abstract":"<p>This unit describes an effective method for the preparation of <i>N</i><sup>6</sup>-benzyl-2′,3′,5′-tri-<i>O</i>-nicotinoyl adenosine and <i>N</i><sup>6</sup>-(3-fluorobenzyl)-2′,3′,5′-tri-<i>O</i>-nicotinoyl adenosine. These compounds are depot forms of biologically active <i>N</i><sup>6</sup>-benzyladenosine (BAR) and its fluorinated analog <i>N</i><sup>6</sup>-(3-fluorobenzyl)adenosine (FBAR), which had previously shown pronounced antiviral activity against human enterovirus EV-A71. BAR and FBAR bearing biodegradable <i>O</i>-nicotinoyl ester moieties were obtained by a three-step synthesis starting from inosine. An attractive feature of this strategy is the possibility of obtaining biodegradable depot forms of various biologically active ribonucleoside derivatives, particularly <i>N</i><sup>6</sup>-substituted adenosine derivatives. © 2025 Wiley Periodicals LLC.</p><p><b>Basic Protocol</b>: Preparation of <i>N</i><sup>6</sup>-benzyl-2′,3′,5′-tri-<i>O</i>-nicotinoyl adenosine (4a).</p><p><b>Alternate Protocol</b>: Preparation of <i>N</i><sup>6</sup>-(3-fluorobenzyl)-2′,3′,5′-tri-<i>O</i>-nicotinoyl adenosine (4b).</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"5 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current protocols","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cpz1.70121","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This unit describes an effective method for the preparation of N6-benzyl-2′,3′,5′-tri-O-nicotinoyl adenosine and N6-(3-fluorobenzyl)-2′,3′,5′-tri-O-nicotinoyl adenosine. These compounds are depot forms of biologically active N6-benzyladenosine (BAR) and its fluorinated analog N6-(3-fluorobenzyl)adenosine (FBAR), which had previously shown pronounced antiviral activity against human enterovirus EV-A71. BAR and FBAR bearing biodegradable O-nicotinoyl ester moieties were obtained by a three-step synthesis starting from inosine. An attractive feature of this strategy is the possibility of obtaining biodegradable depot forms of various biologically active ribonucleoside derivatives, particularly N6-substituted adenosine derivatives. © 2025 Wiley Periodicals LLC.
Basic Protocol: Preparation of N6-benzyl-2′,3′,5′-tri-O-nicotinoyl adenosine (4a).
Alternate Protocol: Preparation of N6-(3-fluorobenzyl)-2′,3′,5′-tri-O-nicotinoyl adenosine (4b).
具有生物活性的n6 -苄基腺苷类似物o -烟酰取代的仓库形式的合成
本单元介绍了一种制备N6-苄基-2′,3′,5′-三- o -烟碱腺苷和N6-(3-氟苯)-2′,3′,5′-三- o -烟碱腺苷的有效方法。这些化合物是具有生物活性的N6-苄基腺苷(BAR)及其氟化类似物N6-(3-氟苄基)腺苷(FBAR)的储存形式,它们先前已显示出对人类肠道病毒EV-A71的明显抗病毒活性。以肌苷为起始原料,通过三步合成得到了具有可生物降解的邻烟酰酯部分的BAR和FBAR。这种策略的一个吸引人的特点是有可能获得各种生物活性核糖核苷衍生物,特别是n6取代腺苷衍生物的可生物降解的储存形式。©2025 Wiley期刊公司。基本方案:n6 -苄基-2 ',3 ',5 ' -三- o -烟碱腺苷的制备(4a)。备选方案:制备N6-(3-氟苯)-2 ',3 ',5 ' -三- o -烟酰腺苷(4b)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。